Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000455177 | SCV000540644 | uncertain significance | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Gene associated with Haemophagocytic lymphohistiocytosis. This variant has been identified in the compound het state with a potential LOF in an individual with reduced levels of B-lymphocytes and IgGs (PMID 25502423). |
Invitae | RCV000548831 | SCV000638950 | benign | Familial hemophagocytic lymphohistiocytosis 3 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000548831 | SCV001283019 | uncertain significance | Familial hemophagocytic lymphohistiocytosis 3 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Ce |
RCV001703174 | SCV001961726 | likely benign | not provided | 2022-05-01 | criteria provided, single submitter | clinical testing | UNC13D: BP4, BS1 |
Genetic Services Laboratory, |
RCV000455177 | SCV002066307 | likely benign | not specified | 2021-12-01 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002263693 | SCV002543024 | uncertain significance | Autoinflammatory syndrome | 2021-04-13 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003912793 | SCV004731949 | likely benign | UNC13D-related disorder | 2022-07-28 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV001703174 | SCV001931463 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001703174 | SCV001970946 | likely benign | not provided | no assertion criteria provided | clinical testing |